Accelerant price target lowered to $15 from $16 at Morgan Stanley

Morgan Stanley analyst Bob Huang lowered the firm’s price target on Accelerant (ARX) to $15 from $16 and keeps an Equal Weight rating on the shares. The firm adjusted target s in the property and casualty insurance group as part of a Q1 earnings preview. The sector’s solid underwriting will be offset by continued pricing softening, the analyst tells investors in a research note. Morgan Stanley remains “generally negative” on personal lines and says reinsurers “should maintain stability.”